KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Non Operating Investment Income (2018)

Arbutus Biopharma's Non Operating Investment Income history spans 1 years, with the latest figure at $24.9 million for Q2 2018.

  • For Q2 2018, Non Operating Investment Income changed N/A year-over-year to $24.9 million; the TTM value through Sep 2019 reached $24.9 million, changed 0.0%, while the annual FY2018 figure was $24.9 million, N/A changed from the prior year.
  • Non Operating Investment Income for Q2 2018 was $24.9 million at Arbutus Biopharma.
  • Across five years, Non Operating Investment Income topped out at $24.9 million in Q2 2018 and bottomed at $24.9 million in Q2 2018.